STOCK TITAN

FMR discloses 7.1% Annexon (NASDAQ: ANNX) holding in 13G/A update

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

FMR LLC has filed Amendment No. 5 to a Schedule 13G/A reporting its beneficial ownership in Annexon Inc. common stock. As of the event date of 12/31/2025, FMR LLC and related entities report beneficial ownership of 10,222,470.36 shares, representing 7.1% of Annexon’s common stock.

FMR LLC has sole voting power over 10,216,569 shares and sole dispositive power over 10,222,470.36 shares, with no shared voting or dispositive power. The filing states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Annexon.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



FMR LLC
Signature:Stephanie J. Brown
Name/Title:Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
Date:02/04/2026
Abigail P. Johnson
Signature:Stephanie J. Brown
Name/Title:Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson**
Date:02/04/2026

Comments accompanying signature: * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. ** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.
Exhibit Information

Please see Exhibit 99 for 13d-1(k) (1) agreement.

FAQ

What percentage of Annexon (ANNX) shares does FMR LLC report owning?

FMR LLC reports beneficial ownership of 7.1% of Annexon’s common stock. This corresponds to 10,222,470.36 shares as of the event date, giving FMR a significant institutional stake while remaining a non-controlling, passive investor under Schedule 13G rules.

How many Annexon (ANNX) shares does FMR LLC have voting and dispositive power over?

FMR LLC has sole voting power over 10,216,569 shares and sole dispositive power over 10,222,470.36 shares. It reports zero shared voting or dispositive power, indicating control over how these shares are voted and whether they are sold or held.

Who are the reporting persons in this Annexon (ANNX) Schedule 13G/A filing?

The reporting persons are FMR LLC and Abigail P. Johnson. FMR LLC is the parent holding company, and Johnson is identified with sole dispositive power over the same 10,222,470.36 shares, reflecting her control position related to FMR’s holdings.

Is FMR LLC seeking to influence control of Annexon (ANNX) with this stake?

The filing states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Annexon. It is a passive ownership disclosure under Schedule 13G, not an activist or control filing.

What is the significance of Amendment No. 5 to the Annexon (ANNX) Schedule 13G/A?

Amendment No. 5 updates FMR LLC’s reported beneficial ownership in Annexon common stock to 10,222,470.36 shares, or 7.1% of the class. Schedule 13G amendments keep the market informed when large institutional positions change or cross regulatory reporting thresholds.

Do others share in the economic interest of FMR’s Annexon (ANNX) holdings?

The filing notes that one or more other persons have rights to receive dividends or sale proceeds from these Annexon shares. However, it specifies that no single such person has an interest equal to or exceeding 5% of the total outstanding common stock.
Annexon, Inc.

NASDAQ:ANNX

ANNX Rankings

ANNX Latest News

ANNX Latest SEC Filings

ANNX Stock Data

900.30M
134.89M
0.42%
100.05%
9.22%
Biotechnology
Pharmaceutical Preparations
Link
United States
BRISBANE